GroupKALSHI

Event GroupKALSHIScience and Technology

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Total Volume

$0.00

Events

Markets

Trade on Kalshi

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Vol

$0.00

Events

Markets

Kalshi

Platform StatsQuick Platform Comparison

Polymarket

markets · $0.00

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Price ChartMatched Markets Price Graph

6 markets tracked

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

No data available

Single-Platform Markets(6)

Market	Platform	Price
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)	Kalshi	78%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)	Kalshi	72%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)	Kalshi	71%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)	Kalshi	64%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)	Kalshi	54%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September)	Kalshi	35%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

78%

Top Probability

$0.00

Volume

Markets

Platforms

About This Event

Lonvoguran Ziclumeran (lonvo-z) - BLA If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran, lonvo-z, to the FDA before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Friday, July 10, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** When will Intellia Therapeutics submit a BLA for Lonvo-z?
**Category:** Science and Technology | **Status:** active
**Resolution Date:** N/A (Unknown)
**Time Pressure:** Unknown

**Description:** Lonvoguran Ziclumeran (lonvo-z) - BLA

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran, lonvo-z, to the FDA before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

**Resolution Criteria (Sample):**
"If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs."

## 2. Market liquidity & Volume
* **Total Volume:** $0
* **Total Liquidity:** $0
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.00)

## 3. Market Data (Prices & Odds)
### 1. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)
- **Kalshi** (End: Jan 8, 2027): Vol $0
  DATA: [Yes: 71.5% (0.0%)] | [No: 28.5% (0.0%)]

### 2. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)
- **Kalshi** (End: Apr 8, 2027): Vol $0
  DATA: [Yes: 78.0% (0.0%)] | [No: 22.0% (0.0%)]

### 3. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September)
- **Kalshi** (End: Sep 8, 2026): Vol $0
  DATA: [Yes: 35.0% (0.0%)] | [No: 65.0% (0.0%)]

### 4. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)
- **Kalshi** (End: Oct 8, 2026): Vol $0
  DATA: [Yes: 54.5% (0.0%)] | [No: 45.5% (0.0%)]

### 5. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)
- **Kalshi** (End: Nov 8, 2026): Vol $0
  DATA: [Yes: 64.0% (0.0%)] | [No: 36.0% (0.0%)]

### 6. When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)
- **Kalshi** (End: Dec 8, 2026): Vol $0
  DATA: [Yes: 71.0% (0.0%)] | [No: 29.0% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

KALSHIScience and Technology

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Volume$0.00

Markets6

6 of 6

Sort:

KALSHI

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

KALSHI

KKalshi

Yes 78.0¢No 22.0¢

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

KALSHI

KKalshi

Yes 71.5¢No 28.5¢

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

KALSHI

KKalshi

Yes 71.0¢No 29.0¢

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

KALSHI

KKalshi

Yes 64.0¢No 36.0¢

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

KALSHI

KKalshi

Yes 54.5¢No 45.5¢

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

No related news found

Discussion

0 Comments

Market Insights

Average Yes Price

62¢

Kalshi

Arbitrage Opps

Cross-Platform

Embed Widget

Add this market to your website

Volume

Platforms

HTML

<iframe src="https://predictpedia.com/embed/CQdin6" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="When will Intellia Therapeutics submit a BLA for Lonvo-z?"></iframe>

Trade This Market

Trade on Kalshi

When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

AI Analysis

About This Event

Custom AI Analysis Prompt

Educational Context

Events (1)

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Markets (6)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

Related News & Context

Discussion

Market Insights

Share

Embed Widget

Trade This Market

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

Custom AI Analysis Prompt

When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

Related News & Context

Discussion

Share

Embed Widget